InvestorsHub Logo
Followers 23
Posts 532
Boards Moderated 1
Alias Born 11/20/2018

Re: 7Card post# 17611

Monday, 02/04/2019 12:30:28 PM

Monday, February 04, 2019 12:30:28 PM

Post# of 113120
This is where the real money is. I see the licencing deals for NS coming out of Europe and Scandinavia. Gamba Natural will probably be the first one announced. This one won't move the needle too much but it will be a small recurring revenue stream. The big ones will come later. I don't see NS licensing Shrimp in the US while producing as well. Not going to help the competition. Europe is another story. Why deal with overseas regulations that vary from country to country. Let someone else deal with that headache while generating revenue streams that could eclipse the US production.

When it comes too other aquatic species I don't have a good feel yet for how they'll play that one. They have to work with F&T since it's 50/50 so they'll likely need to license those deals in the US and overseas.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SHMP News